The average selling price for ORSIRO in Belgium dropped in 2022, according to GlobalData. The average selling price, the complete price range of high and low prices and a 3-year forecast for the ORSIRO device in Belgium can be viewed in GlobalData’s micro pricing report. Buy the report here.
The ORSIRO is sold by Biotronik Se & Co Kg in the Coronary Stents – DES market. Drug eluting stents (DES) release drugs locally and can be coated with a polymeric material. The stent releases an antiproliferative or immunosuppressive drug over time, leaving behind the metallic stent in the artery.
Factors contributing to the list price of a medical device include but are not limited to therapy area, complexity of procedure, level of reimbursement, development costs, the number of competing manufacturers, product life cycle, and whether there have been any recent new technology or product launches. Moreover, final selling prices vary geographically and by facility type. These prices are further subject to discounts, as well as purchasing and distribution agreements.
For a complete picture of Biotronik Se & Co Kg’ Coronary Stents – DES device pricing in Belgium, buy the report here.